139 related articles for article (PubMed ID: 3834071)
1. The macromolecular binding of prednisone in plasma of healthy volunteers including pregnant women and oral contraceptive users.
Gustavson LE; Benet LZ
J Pharmacokinet Biopharm; 1985 Dec; 13(6):561-9. PubMed ID: 3834071
[TBL] [Abstract][Full Text] [Related]
2. Prednisolone disposition and protein binding in oral contraceptive users.
Boekenoogen SJ; Szefler SJ; Jusko WJ
J Clin Endocrinol Metab; 1983 Apr; 56(4):702-9. PubMed ID: 6833459
[TBL] [Abstract][Full Text] [Related]
3. Alterations in prednisolone disposition as a result of oral contraceptive use and dose.
Meffin PJ; Wing LM; Sallustio BC; Brooks PM
Br J Clin Pharmacol; 1984 Jun; 17(6):655-64. PubMed ID: 6743464
[TBL] [Abstract][Full Text] [Related]
4. The effect of altered prednisolone kinetics in patients with the nephrotic syndrome and in women taking oral contraceptive steroids on human mixed lymphocyte cultures.
Frey BM; Frey FJ
J Clin Endocrinol Metab; 1985 Feb; 60(2):361-9. PubMed ID: 3155524
[TBL] [Abstract][Full Text] [Related]
5. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy.
Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A
Popul Sci; 1982; (3):157-68. PubMed ID: 12266214
[TBL] [Abstract][Full Text] [Related]
6. Insulin receptors in circulating erythrocytes and monocytes from women on oral contraceptives or pregnant women near term.
Tsibris JC; Raynor LO; Buhi WC; Buggie J; Spellacy WN
J Clin Endocrinol Metab; 1980 Oct; 51(4):711-7. PubMed ID: 6998996
[TBL] [Abstract][Full Text] [Related]
7. [Cortisol (not protein binded) in women during pregnancy or oral contraceptive medication (author's transl)].
Racadot A; Lefebvre J; Marchandise X; Lesaffre J; Linquette M
Ann Endocrinol (Paris); 1974; 35(3):256-7. PubMed ID: 4463786
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interaction of contraceptive steroids with prednisone and prednisolone.
Frey BM; Schaad HJ; Frey FJ
Eur J Clin Pharmacol; 1984; 26(4):505-11. PubMed ID: 6734709
[TBL] [Abstract][Full Text] [Related]
9. Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.
Frey FJ; Frey BM
Am J Kidney Dis; 1984 Mar; 3(5):339-48. PubMed ID: 6702820
[TBL] [Abstract][Full Text] [Related]
10. Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination.
Cullberg G; Samsioe G; Andersen RF; Bredesgaard P; Andersen NB; Ernerot H; Fanøe E; Fylling P; Haack-Sørensen PE; Klottrup P; Pedersen JH; Sandager T
Contraception; 1982 Sep; 26(3):229-43. PubMed ID: 6217028
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum.
Kuhnz W; Baumann A; Staks T; Dibbelt L; Knuppen R; Jütting G
Contraception; 1993 Oct; 48(4):303-22. PubMed ID: 8222659
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.
Kuhnz W; al-Yacoub G; Fuhrmeister A
Contraception; 1992 Nov; 46(5):455-69. PubMed ID: 1458892
[TBL] [Abstract][Full Text] [Related]
13. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
[TBL] [Abstract][Full Text] [Related]
14. Plasma protein binding interaction of prednisone and prednisolone.
Boudinot FD; Jusko WJ
J Steroid Biochem; 1984 Sep; 21(3):337-9. PubMed ID: 6492791
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding.
Bergink EW; Holma P; Pyörälä T
Scand J Clin Lab Invest; 1981 Nov; 41(7):663-8. PubMed ID: 6461916
[TBL] [Abstract][Full Text] [Related]
16. Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel.
Basdevant A; Conard J; Pelissier C; Guyene TT; Lapousterle C; Mayer M; Guy-Grand B; Degrelle H
Contraception; 1993 Sep; 48(3):193-204. PubMed ID: 8222650
[TBL] [Abstract][Full Text] [Related]
17. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
Hammerstein J; Daume E; Simon A; Winkler UH; Schindler AE; Back DJ; Ward S; Neiss A
Contraception; 1993 Mar; 47(3):263-81. PubMed ID: 8462317
[TBL] [Abstract][Full Text] [Related]
18. Antithrombin III in oral contraceptive users and during normotensive pregnancy.
Weenink GH; Kahlé LH; Lamping RJ; ten Cate JW; Treffers PE
Acta Obstet Gynecol Scand; 1984; 63(1):57-61. PubMed ID: 6720257
[TBL] [Abstract][Full Text] [Related]
19. Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid.
Miners JO; Grgurinovich N; Whitehead AG; Robson RA; Birkett DJ
Br J Clin Pharmacol; 1986 Aug; 22(2):135-42. PubMed ID: 3756063
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
Kuhnz W; Staks T; Jütting G
Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
